Comparative Efficacy of Triple Versus Quadruple Therapy for the Eradication of Helicobacter pylori Infection in Asian Adults—A Systematic Review and Meta‐Analysis
ABSTRACT Helicobacter pylori infection remains a major health issue in Asia due to its strong association with gastric ulcers and cancer. Rising antibiotic resistance has reduced the success of standard triple therapy, leading to broader use of bismuth‐based quadruple regimens. However, the relative...
| Published in: | JGH Open |
|---|---|
| Main Authors: | Abdur Razzak, Nymur Rahman, Nikkon Sarker, Monira Swapna Nil, Md. Arifur Rahman, Md. Toslim Mahmud |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-10-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jgh3.70292 |
Similar Items
Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach
by: Abdur Razzak, et al.
Published: (2025-09-01)
by: Abdur Razzak, et al.
Published: (2025-09-01)
Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01)
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01)
Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
by: Fariborz Mansour-Ghanaei, et al.
Published: (2017-04-01)
by: Fariborz Mansour-Ghanaei, et al.
Published: (2017-04-01)
The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2018-04-01)
by: Soohoon Kwon, et al.
Published: (2018-04-01)
Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy
by: Salma Souissi, et al.
Published: (2024-12-01)
by: Salma Souissi, et al.
Published: (2024-12-01)
The importance of bismuth-containing quadruple therapy in Helicobacter pylori eradication in an era of increasing antibiotic resistance
by: Yi HU, et al.
Published: (2020-06-01)
by: Yi HU, et al.
Published: (2020-06-01)
Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication
by: Yi-Zhou Jiang, et al.
Published: (2025-04-01)
by: Yi-Zhou Jiang, et al.
Published: (2025-04-01)
Clinical and Pharmacological Aspects of Resistance to Eradication Therapy of Helicobacter Pylori Infection
by: S. Yu. Serebrova, et al.
Published: (2020-05-01)
by: S. Yu. Serebrova, et al.
Published: (2020-05-01)
Sequential therapy versus quadruple therapy for Helicobacter pylori eradication: A prospective double‐blinded randomized controlled trial
by: Elham Tabesh, et al.
Published: (2024-01-01)
by: Elham Tabesh, et al.
Published: (2024-01-01)
The Efficacy of Levofloxacin versus Clarithromycin in Primary Quadruple Therapy for the Eradication of Helicobacter Pylori: A Prospective Randomized Controlled Clinical Trial Study
by: Vahid Sebghatollahi, et al.
Published: (2020-06-01)
by: Vahid Sebghatollahi, et al.
Published: (2020-06-01)
Eradication Therapy for Pediatric Helicobacter pylori Infection
by: Ji-Hyun Seo, et al.
Published: (2017-03-01)
by: Ji-Hyun Seo, et al.
Published: (2017-03-01)
Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01)
by: Qiyunna He, et al.
Published: (2024-05-01)
Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
by: Arash Kazemi, et al.
Published: (2023-09-01)
by: Arash Kazemi, et al.
Published: (2023-09-01)
Effects of Helicobacter pylori and Helicobacter pylori eradication on the microbiota of tongue coating
by: Chao Li, et al.
Published: (2024-10-01)
by: Chao Li, et al.
Published: (2024-10-01)
Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
Published: (2012-10-01)
Published: (2012-10-01)
Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
by: Fahad Alsohaibani, et al.
Published: (2020-01-01)
by: Fahad Alsohaibani, et al.
Published: (2020-01-01)
Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01)
by: Tae Jun Kim, et al.
Published: (2021-12-01)
Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication
by: Eun Jin Kim, et al.
Published: (2017-12-01)
by: Eun Jin Kim, et al.
Published: (2017-12-01)
Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017-03-01)
by: Gwang Ha Kim
Published: (2017-03-01)
Serum Assay Findings after Successful Helicobacter pylori Eradication
by: Sun-Young Lee
Published: (2021-12-01)
by: Sun-Young Lee
Published: (2021-12-01)
Eradication of Helicobacter Pylori
by: V. V. Tsukanov, et al.
Published: (2015-12-01)
by: V. V. Tsukanov, et al.
Published: (2015-12-01)
Helicobacter pylori Eradication and Gastric Cancer Prevention
by: Chan Hyuk Park
Published: (2021-12-01)
by: Chan Hyuk Park
Published: (2021-12-01)
Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection
Published: (2015-05-01)
Published: (2015-05-01)
Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
Published: (2012-10-01)
Published: (2012-10-01)
Ghrelin Levels in Gastric Mucosa before and after Eradication of Helicobacter pylori
Published: (2007-12-01)
Published: (2007-12-01)
IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION
by: Luiz Gonzaga Vaz COELHO, et al.
Published: (2018-04-01)
by: Luiz Gonzaga Vaz COELHO, et al.
Published: (2018-04-01)
Amoxicillin or tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis
by: Kunping Ju, et al.
Published: (2025-09-01)
by: Kunping Ju, et al.
Published: (2025-09-01)
II Consenso Brasileiro sobre Helicobacter pylori Second Brazilian Consensus Conference on Helicobacter pylori infection
by: Luiz Gonzaga Vaz Coelho, et al.
Published: (2005-06-01)
by: Luiz Gonzaga Vaz Coelho, et al.
Published: (2005-06-01)
The significance of chronic hyperglycemia for the reduced efficacy of eradication therapy in patients with type 2 diabetes mellitus and for Helicobacter pylori survival
by: Luiza Gilmanovna Bektemirova, et al.
Published: (2023-12-01)
by: Luiza Gilmanovna Bektemirova, et al.
Published: (2023-12-01)
Efficacy of Adding Lactoferrin with Triple Therapy for Helicobacter Pylori Eradication in Egyptian Patients
by: Abdelrhman Elsayed, et al.
Published: (2023-09-01)
by: Abdelrhman Elsayed, et al.
Published: (2023-09-01)
Helicobacter pylori eradication effects on rheumatic diseases: a systematic review
by: J. Freire de Carvalho, et al.
Published: (2023-06-01)
by: J. Freire de Carvalho, et al.
Published: (2023-06-01)
Study of the Role of Garlic Consumption in Helicobacter Pylori Eradication
by: M Ghobeh, et al.
Published: (2010-09-01)
by: M Ghobeh, et al.
Published: (2010-09-01)
Helicobacter pylori Eradication Rate in Patients with Diabetes
by: Jiyeon Yoo, et al.
Published: (2017-06-01)
by: Jiyeon Yoo, et al.
Published: (2017-06-01)
Helicobacter pylori eradication in renal transplant candidates
by: Mariana E. Maioli, et al.
Published: (2022-01-01)
by: Mariana E. Maioli, et al.
Published: (2022-01-01)
Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China
by: Jianping Cheng, et al.
Published: (2025-08-01)
by: Jianping Cheng, et al.
Published: (2025-08-01)
Minocycline/Amoxicillin-Based Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Pilot Study
by: Senlin You, et al.
Published: (2024-02-01)
by: Senlin You, et al.
Published: (2024-02-01)
Correlation analysis of endoscopic manifestations and eradication effect of Helicobacter pylori
by: Xin Luo, et al.
Published: (2023-08-01)
by: Xin Luo, et al.
Published: (2023-08-01)
Randomized Controlled Trial Comparing Standard Triple and Sequential Regimens for Helicobacter pylori Eradication
by: Byambajav Tsogt-Ochir, et al.
Published: (2016-11-01)
by: Byambajav Tsogt-Ochir, et al.
Published: (2016-11-01)
Control of Helicobacter pylori with engineered probiotics secreting selective guided antimicrobial peptides
by: Ankan Choudhury, et al.
Published: (2023-10-01)
by: Ankan Choudhury, et al.
Published: (2023-10-01)
Role of Helicobacter pylori in Rosacea
by: Nazan EMİROĞLU, et al.
Published: (2018-01-01)
by: Nazan EMİROĞLU, et al.
Published: (2018-01-01)
Similar Items
-
Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach
by: Abdur Razzak, et al.
Published: (2025-09-01) -
Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01) -
Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
by: Fariborz Mansour-Ghanaei, et al.
Published: (2017-04-01) -
The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2018-04-01) -
Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy
by: Salma Souissi, et al.
Published: (2024-12-01)
